244 related articles for article (PubMed ID: 31237076)
1. Treatment of chronic extensive alopecia areata by diphenylcyclopropenone alone versus in combination with anthralin.
Ibrahim SA; Esawy AM; Abdelshafy AS
Dermatol Ther; 2019 Sep; 32(5):e13010. PubMed ID: 31237076
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of anthralin in combination with diphenylcyclopropenone in the treatment of alopecia areata: a retrospective case series.
Nasimi M; Ghandi N; Abedini R; Mirshamsi A; Shakoei S; Seirafi H
Arch Dermatol Res; 2019 Oct; 311(8):607-613. PubMed ID: 31165933
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of diphenylcyclopropenone alone or in combination with anthralin in the treatment of chronic extensive alopecia areata: a retrospective case series.
Durdu M; Özcan D; Baba M; Seçkin D
J Am Acad Dermatol; 2015 Apr; 72(4):640-50. PubMed ID: 25653027
[TBL] [Abstract][Full Text] [Related]
4. A randomized trial of diphenylcyclopropenone (DPCP) combined with anthralin versus DPCP alone for treating moderate to severe alopecia areata.
Ghandi N; Daneshmand R; Hatami P; Abedini R; Nasimi M; Aryanian Z; Vance TM
Int Immunopharmacol; 2021 Oct; 99():107971. PubMed ID: 34298402
[TBL] [Abstract][Full Text] [Related]
5. Topical immunotherapy of severe alopecia areata with diphenylcyclopropenone (DPCP): experience in an Iranian population.
Aghaei S
BMC Dermatol; 2005 May; 5():6. PubMed ID: 15918897
[TBL] [Abstract][Full Text] [Related]
6. Clinical Efficacy of Diphenylcyclopropenone in Alopecia Areata: Retrospective Data Analysis of 50 Patients.
Chiang KS; Mesinkovska NA; Piliang MP; Bergfeld WF
J Investig Dermatol Symp Proc; 2015 Nov; 17(2):50-5. PubMed ID: 26551948
[TBL] [Abstract][Full Text] [Related]
7. Treatment of pediatric alopecia areata with anthralin: A retrospective study of 37 patients.
Wu SZ; Wang S; Ratnaparkhi R; Bergfeld WF
Pediatr Dermatol; 2018 Nov; 35(6):817-820. PubMed ID: 30338548
[TBL] [Abstract][Full Text] [Related]
8. Topical immunotherapy in combination with anthralin in the treatment of refractory alopecia areata.
Kagami S; Kishi Y; Hino H
J Cosmet Dermatol; 2020 Sep; 19(9):2411-2414. PubMed ID: 32621407
[TBL] [Abstract][Full Text] [Related]
9. A prospective comparative study of two regimens of diphenylcyclopropenone (DPCP) in the treatment of alopecia areata.
Al Bazzal A; Hatami P; Abedini R; Etesami I; Ayanian Z; Ghandi N
Int Immunopharmacol; 2021 Dec; 101(Pt B):108186. PubMed ID: 34710658
[TBL] [Abstract][Full Text] [Related]
10. Subclinical sensitization with diphenylcyclopropenone is sufficient for the treatment of alopecia areata: Retrospective analysis of 159 cases.
Choe SJ; Lee S; Pi LQ; Keum DI; Lee CH; Kim BJ; Lee WS
J Am Acad Dermatol; 2018 Mar; 78(3):515-521.e4. PubMed ID: 29108907
[TBL] [Abstract][Full Text] [Related]
11. The use of topical diphenylcyclopropenone for the treatment of extensive alopecia areata.
Cotellessa C; Peris K; Caracciolo E; Mordenti C; Chimenti S
J Am Acad Dermatol; 2001 Jan; 44(1):73-6. PubMed ID: 11148480
[TBL] [Abstract][Full Text] [Related]
12. Higher concentrations of dithranol appear to induce hair growth even in severe alopecia areata.
Ngwanya MR; Gray NA; Gumedze F; Ndyenga A; Khumalo NP
Dermatol Ther; 2017 Jul; 30(4):. PubMed ID: 28598005
[TBL] [Abstract][Full Text] [Related]
13. Diphenylcyclopropenone (diphencyprone, DPCP) in the treatment of chronic severe alopecia areata (AA).
Galadari I; Rubaie S; Alkaabi J; Galadari H
Eur Ann Allergy Clin Immunol; 2003 Dec; 35(10):397-401. PubMed ID: 14768526
[TBL] [Abstract][Full Text] [Related]
14. Topical immunotherapy with diphenylcyclopropenone in the treatment of chronic extensive alopecia areata.
Sotiriadis D; Patsatsi A; Lazaridou E; Kastanis A; Vakirlis E; Chrysomallis F
Clin Exp Dermatol; 2007 Jan; 32(1):48-51. PubMed ID: 17004987
[TBL] [Abstract][Full Text] [Related]
15. Topical immunomodulation with diphenylcyclopropenone for alopecia areata: the Lebanese experience.
El Khoury J; Abd-el-Baki J; Succariah F; Abbas O; Kibbi AG; Kurban M
Int J Dermatol; 2013 Dec; 52(12):1551-6. PubMed ID: 24134785
[TBL] [Abstract][Full Text] [Related]
16. Recalcitrant alopecia areata responsive to leflunomide and anthralin-Potentially undiscovered JAK/STAT inhibitors?
Sardana K; Gupta A; Gautam RK
Pediatr Dermatol; 2018 Nov; 35(6):856-858. PubMed ID: 30318623
[TBL] [Abstract][Full Text] [Related]
17. Serum level of IL-4 predicts response to topical immunotherapy with diphenylcyclopropenone in alopecia areata.
Gong Y; Zhao Y; Zhang X; Qi S; Li S; Ye Y; Yang J; Caulloo S; McElwee KJ; Zhang X
Exp Dermatol; 2020 Mar; 29(3):231-238. PubMed ID: 30047620
[TBL] [Abstract][Full Text] [Related]
18. Hair Regrowth Outcomes of Contact Immunotherapy for Patients With Alopecia Areata: A Systematic Review and Meta-analysis.
Lee S; Kim BJ; Lee YB; Lee WS
JAMA Dermatol; 2018 Oct; 154(10):1145-1151. PubMed ID: 30073292
[TBL] [Abstract][Full Text] [Related]
19. Assessment of treatment efficacy of diphenylcyclopropenone (DPCP) for alopecia areata.
Kutlubay Z; Sevim A; Aydın Ö; Vehid S; Serdaroğlu S
Turk J Med Sci; 2020 Dec; 50(8):1817-1824. PubMed ID: 31655499
[TBL] [Abstract][Full Text] [Related]
20. A systematic review on the treatment of pediatric severe alopecia areata by topical immunotherapy or Anthralin (contact sensitization) or low-level light/laser therapy (LLLT): focus on efficacy, safety, treatment duration, recurrence, and follow-up based on clinical studies.
Behrangi E; Roohaninasab M; Sadeghzadeh-Bazargan A; Najar Nobari N; Ghassemi M; Seirafianpour F; Goodarzi A; Dodangeh M
J Cosmet Dermatol; 2022 Jul; 21(7):2727-2741. PubMed ID: 34606676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
